Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
100%(5 trials)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Novel Multifocal Soft Contact Lens Study

NCT06172881
completednot_applicable

A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens

NCT01518868
completedphase_2

Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance

NCT03330275
completednot_applicable

Evaluation of Astigmatic Contact Lenses

NCT03086447
completednot_applicable

Feasibility of a New Silicone Hydrogel Lens

NCT01131130

Clinical Trials (5)

Showing 5 of 5 trials
NCT06172881Not Applicable

Novel Multifocal Soft Contact Lens Study

Completed
NCT01518868Not Applicable

A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens

Completed
NCT03330275Phase 2

Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance

Completed
NCT03086447Not Applicable

Evaluation of Astigmatic Contact Lenses

Completed
NCT01131130Not Applicable

Feasibility of a New Silicone Hydrogel Lens

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5